keyword
https://read.qxmd.com/read/38654963/outcomes-of-anorexia-nervosa-in-a-male-patient-treated-with-paroxetine-a-case-report
#1
Mohammed Alkhamis, Waad D Alotaibi, Ghaiah J Alharbi, Anwar M Alsaeed, Fatimah A Almuhaysin
Eating disorders (EDs) are among the most dangerous mental illnesses, that are characterized by high mortality rates, multisystem comorbidity, and an often chronic and relapsing disease course. EDs occur most commonly in the female gender, with a ratio of 10 females to 1 male for anorexia nervosa (AN). We present the case of a 15-year-old Saudi boy who presented with weight loss (BMI 11.6 kg/m2 ) and began to have symptoms of obsessive-compulsive disorder (OCD) in prayer and ablution. His first treatment plan was psychoeducation...
April 2024: Curēus
https://read.qxmd.com/read/38654374/severe-enduring-anorexia-nervosa-se-an-treatment-options-and-their-effectiveness-a-review-of-literature
#2
REVIEW
Federica Marcolini, Alessandro Ravaglia, Silvia Tempia Valenta, Giovanna Bosco, Giorgia Marconi, Diana De Ronchi, Anna Rita Atti
INTRODUCTION:  For nearly 20% of patients diagnosed with Anorexia Nervosa (AN), the eating disorder (ED) is prolonged and becomes long-lasting. It has been reported that patients diagnosed with Severe Enduring Anorexia Nervosa (SE-AN) have worse ED symptoms, higher rates of lifetime hospitalization, and lower psychosocial well-being compared to patients with shorter disease duration. OBJECTIVES:  This review aims to describe the treatments proposed to date and their effectiveness on SE-AN-related outcomes...
April 23, 2024: Journal of Eating Disorders
https://read.qxmd.com/read/38653660/haematological-adverse-effects-associated-with-olanzapine-in-adolescents-with-anorexia-nervosa-three-case-reports
#3
Elard Bottoni-Tito, Wendy Messa-Aguilar
OBJECTIVES: To describe haematological adverse effects in adolescents with anorexia nervosa who are taking olanzapine. METHODS: Case series report. CASE REPORT: The reported cases (two female patients and one male) were found to have blood test abnormalities after starting olanzapine and to rapidly recover their platelet and neutrophil values after the drug was discontinued. Low haemoglobin values persisted longer than observed in other series...
April 22, 2024: Revista Colombiana de psiquiatría (English ed.)
https://read.qxmd.com/read/38650516/-intensive-exposure-treatment-for-obsessive-compulsive-disorder-in-old-age
#4
JOURNAL ARTICLE
M G Guineau, R C Oude Voshaar, G-J Hendriks
The absence of treatment studies for obsessive compulsive disorder (OCD) in older adults and the fact that OCD typically starts at a young age and often follows a chronic, fluctuating course quickly leads to therapeutic nihilism for older adults with OCD. In this case report, we present a 72-year-old man with OCD symptoms from the age of 35, who has only been treated with medication and psychotherapy for a recurrent depressive disorder. After a short, intensive exposure and response prevention treatment (four days in two weeks), the OCD symptoms and the depressive symptoms were fully in remission and all medications (venlafaxine, olanzapine, depakine) were discontinued...
2024: Tijdschrift Voor Psychiatrie
https://read.qxmd.com/read/38649302/prior-psychiatric-morbidity-and-differential-psychopharmacological-treatment-patterns-exploring-the-heterogeneity-of-bipolar-disorder-in-a-nationwide-study-of-9594-patients
#5
JOURNAL ARTICLE
Aswin Ratheesh, Maria Speed, Estela Salagre, Michael Berk, Christopher Rohde, Søren Dinesen Østergaard
OBJECTIVES: Individuals with bipolar disorders (BD) have heterogenic pre-onset illness courses and responses to treatment. The pattern of illness preceding the diagnosis of BD may be a marker of future treatment response. Here, we examined associations between psychiatric morbidity preceding the diagnosis of BD and pharmacological treatment patterns in the 2 years following diagnosis. METHODS: In this register-based study, we included all patients with a diagnosis of BD attending Danish Psychiatric Services between January 1, 2012 and December 31, 2016...
April 22, 2024: Bipolar Disorders
https://read.qxmd.com/read/38646425/olanzapine-for-the-prevention-of-postoperative-nausea-and-vomiting-after-gynecologic-laparoscopic-surgery-a-randomized-controlled-trial
#6
JOURNAL ARTICLE
Nanjin Chen, Shuman Ji, Junfei Liu, Liping Wang, Fenglin Chen, Yanwu Zhu, Jiao Li, Minjuan Chen, Lingyang Chen, Mingcang Wang, Ruyi He, Xiaopeng Mei, Zhanqin Zhang, Shengwei Jin, Jingming Zheng, Yongpo Jiang
PURPOSE: This study was designed to investigate the prophylactic effect of oral olanzapine in postoperative nausea and vomiting after gynecologic laparoscopic surgery. METHODS: ASA I-II, aged 18-75 years, planned to undergo gynecologic laparoscopic surgery with general anesthesia in adult female patients. Using the randomized numbers table, the patients were placed in two groups. Oral olanzapine 5 mg or placebo was given 1 h before anesthesia...
2024: Therapeutic Advances in Drug Safety
https://read.qxmd.com/read/38642423/the-effect-of-differences-in-trial-design-on-estimates-of-efficacy-of-olanzapine-in-randomized-studies
#7
JOURNAL ARTICLE
F Rotella, A Falone, E Cassioli, E Mannucci, V Ricca, F Del Monaco
BACKGROUND: Differences in trial design may affect estimates of efficacy of psychotropic drugs. The purpose of this meta-analysis is to evaluate whether the use of Olanzapine (OLZ) as either investigational or control drug affects the observed efficacy of OLZ. METHODS: We performed a search for Randomized-Controlled Trials (RCTs) in which the efficacy of OLZ is assessed in patients with schizophrenia or schizoaffective disorder. We assessed overall efficacy of OLZ and performed subgroup analyses of studies with OLZ as intervention or comparator...
April 12, 2024: Psychiatry Research
https://read.qxmd.com/read/38639444/the-treatment-of-brux%C3%A4-sm-assoc%C3%A4-ated-with-fluoxet%C3%A4-ne-us%C3%A4-ng-olanzapine-in-10-year-old-child-case-report
#8
JOURNAL ARTICLE
Öznur Adıgüzel Akman
No abstract text is available yet for this article.
April 19, 2024: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/38635860/vitamin-d3-and-zinc-supplements-augment-the-antimanic-efficacy-of-lithium-and-olanzapine-treatments-in-an-animal-model-of-mania
#9
JOURNAL ARTICLE
Aya A S Huzayyin, Michael K Ibrahim, Nahed M A Hassanein, Helmy M S Ahmed
Objective: Bipolar disorder (BD) is a challenging psychiatric disorder and a complex disease. The associated reduction in serum vitamin D3 (VitD3 ) levels in BD patients and the contribution of zinc (Zn) to the treatment, along with the severe side effects of lithium (Li) treatment, were encouraging to assess the efficacy of different correlated combinations of therapeutic/nutraceutical treatments such as olanzapine (Oln), VitD3, and Zn against Li. Methods: Mania was induced in C57BL/6 mice by administering methylphenidate (MPH) for 14 consecutive days...
April 18, 2024: Nutritional Neuroscience
https://read.qxmd.com/read/38635089/rapid-metabolism-underlying-subtherapeutic-serum-levels-of-atypical-antipsychotics-preceding-clozapine-treatment-a-retrospective-analysis-of-real-world-data
#10
JOURNAL ARTICLE
Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell, Ole A Andreassen, Espen Molden
INTRODUCTION: Adequate antipsychotic treatment intensity is required before diagnosing resistant schizophrenia and initiating clozapine treatment. We aimed to investigate potential rapid drug metabolism underlying low dose-adjusted serum concentration (CD) of non-clozapine atypical antipsychotics preceding clozapine treatment. METHODS: Patients using non-clozapine, atypical antipsychotics (aripiprazole, risperidone, olanzapine, or quetiapine) within 1 year before starting clozapine were included in this study from a therapeutic drug monitoring service in Oslo, Norway, between 2005 and 2023...
April 18, 2024: CNS Drugs
https://read.qxmd.com/read/38633733/psychotropic-management-in-cotard-syndrome-case-reports-supporting-dual-medication-management
#11
Adam J Fusick, Chemar Davis, Steven Gunther, Cory Klippel, Gregory Sullivan
Cotard syndrome is a rare presentation where patients present with nihilistic thoughts of dying or already being dead. These delusions manifest from either a medical or psychiatric etiology and can be difficult to treat. Recently Couto and Gonçalves purposed that treatment should include an atypical antipsychotic alone or in combination with either a mood stabilizer or antidepressant. Here the authors advocate for a more specific but well-known psychotropic regimen, namely the combination of olanzapine and fluoxetine...
2024: Case Reports in Psychiatry
https://read.qxmd.com/read/38627211/thirst-and-drugs-a-study-in-the-world-health-organization-s-pharmacovigilance-database
#12
JOURNAL ARTICLE
Jean-Louis Montastruc
Thirst is a complex physiological compensatory mechanism but could also be associated with drugs. This association was poorly investigated previously. Using the WHO global pharmacovigilance database, Vigibase®, disproportionality analyses potential associations between exposure to drugs and thirst reports were performed. All reports of thirst in adults between 01/01/2000 and 31/12/2023 were included. Results are expressed as reporting odds ratio (ROR). Analysis of the 3186 reports of thirst (978 'serious') allowed, first, to confirm the association between thirst and exposure to vasopressin antagonists (tolvaptan), lithium, gliflozins (dapagliflozin, empagliflozin), pregabalin and antimuscarinic drugs (glycopyronium, oxybutynin, tiotropium)...
April 16, 2024: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/38618207/effect-of-antipsychotics-and-mood-stabilisers-on-metabolism-in%C3%A2-bipolar-disorder-a-network-meta-analysis-of-randomised-controlled-trials
#13
JOURNAL ARTICLE
Lingzhuo Kong, Huaizhi Wang, Ning Yan, Chenyue Xu, Yiqing Chen, Yuanyuan Zeng, Xiaonan Guo, Jing Lu, Shaohua Hu
BACKGROUND: Antipsychotics and mood stabilisers are gathering attention for the disturbance of metabolism. This network meta-analysis aims to evaluate and rank the metabolic effects of the commonly used antipsychotics and mood stabilisers in treating bipolar disorder (BD). METHODS: Registries including PubMed, Embase, Cochrane Library, Web of Science, Ovid, and Google Scholar were searched before February 15th, 2024, for randomised controlled trials (RCTs) applying antipsychotics or mood stabilisers for BD treatment...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617187/risk-factors-associated-with-chemotherapy-induced-nausea-and-vomiting-among-women-with-breast-cancer-receiving-highly-emetogenic-chemotherapy-individual-patient-based-analysis-of-three-prospective-antiemetic-trials
#14
JOURNAL ARTICLE
Winnie Yeo, Nicole T Y Ngai, Christopher C H Yip, Frankie K F Mo, Victoria A Yeo, Jonathan W H Ko, Leung V Li, Thomas K H Lau, Kwai Tung Lai, Elizabeth Pang, Claudia H W Yip, Horatio L Yeo, Carol Chi Hei Kwok, Stephanie W Y Ko, Alex Molassiotis
PURPOSE: Although risk factors related to chemotherapy-induced nausea and vomiting (CINV) have been identified in previous studies, only a few studies have evaluated the risk factors associated with contemporary antiemetic prophylaxis, including olanzapine/aprepitant- or NEPA-containing regimens. This study aimed to identify the risk factors associated with CINV development in Chinese breast cancer patients receiving doxorubicin and cyclophosphamide chemotherapy. METHODS: Data from 304 patients enrolled in 3 previously reported prospective antiemetic studies were included...
2024: Cancer Management and Research
https://read.qxmd.com/read/38610838/association-of-antipsychotic-polypharmacy-and-two-year-all-cause-mortality-a-population-based-cohort-study-of-33-221-italian-continuous-users
#15
JOURNAL ARTICLE
Alberto Parabiaghi, Matteo Monzio Compagnoni, Barbara D'Avanzo, Giulia Caggiu, Alessia A Galbussera, Mauro Tettamanti, Ida Fortino, Angelo Barbato
Background: Differences in survival between patients treated with antipsychotic monotherapy vs. polytherapy are debated. This study aimed to examine the association of antipsychotic polytherapy with 2-year all-cause mortality in a population-based cohort. Methods: Data were retrieved from healthcare databases of four local health units of Lombardy, Italy. Subjects aged 18-79 years who received continuous antipsychotic prescriptions in 2018 were identified. Overall survival among patients with antipsychotic monotherapy vs...
April 3, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38607458/antipsychotic-prescribing-national-findings-of-children-and-adolescents-attending-mental-health-services-in-ireland
#16
JOURNAL ARTICLE
David J O Driscoll, Suzanne McCarthy
Antipsychotic prescribing trends vary internationally, albeit off-label use remains high (i.e., target symptoms). We aim to describe antipsychotic use, target conditions, target symptoms and dosing regimens in children and adolescents in Ireland. We used a sampled cohort from a national audit of children and adolescents attending mental health services with predefined inclusion and exclusion criteria from Jul-2021 to Dec-2021 who were prescribed at least one psychotropic medication and up to and including 17-years of age (n = 3528)...
April 12, 2024: European Child & Adolescent Psychiatry
https://read.qxmd.com/read/38599435/mucoadhesive-chitosan-poly-lactic-co-glycolic-acid-nanoparticles-for-intranasal-delivery-of-quetiapine-development-characterization-in-physiologically-relevant-3d-tissue-models
#17
JOURNAL ARTICLE
Dnyandev G Gadhave, Mural Quadros, Akanksha R Ugale, Mimansa Goyal, Seyoum Ayehunie, Vivek Gupta
Quetiapine hemifumarate (QF) delivery to the CNS via conventional formulations is challenging due to poor solubility and lower oral bioavailability (9 %). Similarly, many other second-generation antipsychotics, such as olanzapine, clozapine, and paliperidone, have also shown low oral bioavailability of <50 %. Hence, the present work was intended to formulate QF-loaded biodegradable PLGA-NPs with appropriate surface charge modification through poloxamer-chitosan and investigate its targeting potential on RPMI-2650 cell lines to overcome the limitations of conventional therapies...
April 8, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38582275/continuous-oral-olanzapine-or-clozapine-treatment-initiated-in-adolescence-has-differential-short-and-long-term-impacts-on-antipsychotic-sensitivity-than-those-initiated-in-adulthood
#18
JOURNAL ARTICLE
Ruiyong Wu, Shinnyi Chou, Ming Li
One of the major discoveries in recent research on antipsychotic drugs is that antipsychotic treatment in adolescence could induce robust long-term alterations in antipsychotic sensitivity that persist into adulthood. These long-term impacts are likely influenced by various factors, including the "diseased" state of animals, sex, type of drugs, mode of drug administration, and age of treatment onset. In this study we compared the short- and long-term behavioral effects of 21-day continuous oral olanzapine (7...
April 4, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38579432/antipsychotic-medications-and-sleep-problems-in-patients-with-schizophrenia
#19
JOURNAL ARTICLE
Erik Cederlöf, Minna Holm, Heidi Taipale, Jari Tiihonen, Antti Tanskanen, Markku Lähteenvuo, Kaisla Lahdensuo, Olli Kampman, Asko Wegelius, Erkki Isometsä, Tuula Kieseppä, Aarno Palotie, Jaana Suvisaari, Tiina Paunio
BACKGROUND: Sleep problems are common and related to a worse quality of life in patients with schizophrenia. Almost all patients with schizophrenia use antipsychotic medications, which usually increase sleep. Still, the differences in subjective sleep outcomes between different antipsychotic medications are not entirely clear. METHODS: This study assessed 5466 patients with schizophrenia and is part of the nationwide Finnish SUPER study. We examined how the five most common antipsychotic medications (clozapine, olanzapine, quetiapine, aripiprazole, and risperidone) associate with questionnaire-based sleep problems in logistic regression analyses, including head-to-head analyses between different antipsychotic medications...
April 4, 2024: Schizophrenia Research
https://read.qxmd.com/read/38579267/treating-schizophrenia-and-bipolar-i-disorder-in-the-real-world-setting-effectiveness-and-safety-of-olanzapine-samidorphan-combination
#20
JOURNAL ARTICLE
Maxwell Zachary Price, Richard Louis Price
No abstract text is available yet for this article.
April 2, 2024: Primary Care Companion to CNS Disorders
keyword
keyword
4834
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.